MoonLake Announces Positive Topline Results from the Phase 3 IZAR-1 Trial of Sonelokimab in Psoriatic Arthritis Demonstrating Significant Improvements Across all Clinical ...

Phase 3 IZAR-1 trial in bio-naïve patients met all clinical endpoints at Week 16 for 60 mg sonelokimabThe primary endpoint of ACR50 was met with ...
Medscape

Surgery for Diabetic Gastroparesis Tied to Improved Glycemic Control, Less Complications

A large EHR study finds reduced insulin use and lower rates of diabetes-related complications among patients undergoing ...
Tech Times on MSN

Barrick posts Q2 earnings miss as $1.95B Nevada deal clears year-end gold IPO

Barrick Newmont Nevada Gold Mines deal: Barrick and Newmont reached a $1.95 billion agreement expanding the joint venture to nearly 100 million ounces and securing Newmont's IPO consent, while Barrick ...
sharewise

ADMA Biologics Q2 Earnings Call Highlights

Key Points Interested in ADMA Biologics Inc? Here are five stocks we like better. Second-quarter revenue rose 2% to $124.4 ...

Bright Minds: BMB-101 Takes Center Stage Ahead Of Phase 3 Pivotal Trials

BMB-101 targets drug-resistant epilepsies with strong Phase 2 results and a differentiated safety profile, but Phase 3 risks ...
Science Daily

Absolute zero

Absolute zero is the lowest possible temperature where nothing could be colder and no heat energy remains in a substance. Absolute zero is the point at which the fundamental particles of nature have ...
FIRSTonlineOpinion

Climate and pollution, the Chinese paradox: record renewables but coal remains dominant

The Asian giant is accelerating its race for green technologies and CO02 sequestration, but sticking to its plans to reduce ...